Émilie Gobeil
6PUBLICATIONS
18CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Feb 04, 2026
Integrative genetic and liver transcriptomic analyses identify TRIB1AL as a target for steatotic liver disease.Émilie Gobeil, Jérôme Bourgault, Eloi Gagnon
|May 10, 2025
RNA interference versus antibody-based PCSK9 inhibition for the prevention of cardiovascular disease: a drug-target Mendelian randomization study.Eloi Gagnon, Dipender Gill, Jérôme Bourgault
|Jan 20, 2024
Genetic inhibition of angiopoietin-like protein-3, lipids, and cardiometabolic risk.Émilie Gobeil, Jérôme Bourgault, Patricia L Mitchell
|Oct 17, 2022
Mendelian randomization prioritizes abdominal adiposity as an independent causal factor for liver fat accumulation and cardiometabolic diseases.Eloi Gagnon, William Pelletier, Émilie Gobeil
|May 28, 2022
Mendelian Randomization Analysis Identifies Blood Tyrosine Levels as a Biomarker of Non-Alcoholic Fatty Liver Disease.Émilie Gobeil, Ina Maltais-Payette, Nele Taba
|Dec 28, 2021
Blood Levels of the SMOC1 Hepatokine Are Not Causally Linked with Type 2 Diabetes: A Bidirectional Mendelian Randomization Study.Nooshin Ghodsian, Eloi Gagnon, Jérôme Bourgault
Pageof 1
Frequent Collaborators
5 joint publications
Patricia L Mitchell
5 joint publications
Benoit J Arsenault
5 joint publications
Jérôme Bourgault
5 joint publications
Sébastien Thériault
4 joint publications
Hasanga D Manikpurage
4 joint publications
Marie-Claude Vohl
4 joint publications
Eloi Gagnon
3 joint publications
Yohan Bossé
3 joint publications
Patrick Mathieu
3 joint publications
André Tchernof
